Hagiwara S, Murata M, Aoki M, Kaneko M, Oshima K
Department of Emergency Medicine, Gunma University Graduate School of Medicine, Maebashi, Gunma, Japan.
Hippokratia. 2013 Apr;17(2):171-3.
We report two cases of Klebsiella oxytoca bacteremia. Case 1 was a 56-year-old man who was transferred to our hospital by ambulance due to diarrhea and general fatigue. On arrival, he was clearly conscious. However he was in septic shock. We injected broad spectrum antibacterial agents and started intensive care. Though intensive care included continuous hemodiafiltration (CHDF), he died 22 hours after admission. Case 2 was a 69-year-old man with a history of gastrectomy for gastric cancer. He had been admitted to a previous hospital due to ileus. His ileus tube was removed on the eighth day, and he then developed a fever of 38 ºC on the following day. He went into shock and became unconscious; he was therefore transferred to our hospital. We diagnosed septic shock and disseminated intravascular coagulation (DIC). We injected broad spectrum antibacterial agents, and recombinant thrombomodulin alpha (rTM). Although he was started in intensive care, his hemodynamics were unstable on the day following admission. Extracorporeal membrane oxygenation (ECMO) and intra-aortic balloon pumping (IABP) were started to maintain his hemodynamics. His condition gradually improved, and he was transferred to the previous hospital for rehabilitation on the 28(th) day. ECMO for septic shock in adults is unusual; however ECMO can be introduced even in patients with severe sepsis under careful monitoring. The new anti-DIC agent rTM is useful for safe driving of ECMO in patients with DIC.
我们报告了两例产酸克雷伯菌败血症病例。病例1是一名56岁男性,因腹泻和全身乏力由救护车转运至我院。入院时,他意识清醒,但处于感染性休克状态。我们注射了广谱抗菌药物并开始进行重症监护。尽管重症监护包括持续血液透析滤过(CHDF),但他在入院22小时后死亡。病例2是一名69岁男性,有因胃癌行胃切除术的病史。他因肠梗阻入住前一家医院。在第八天拔除了肠梗阻导管,随后第二天体温升至38℃。他陷入休克并失去意识,因此被转至我院。我们诊断为感染性休克和弥散性血管内凝血(DIC)。我们注射了广谱抗菌药物和重组血栓调节蛋白α(rTM)。尽管他开始接受重症监护,但入院次日其血流动力学仍不稳定。开始采用体外膜肺氧合(ECMO)和主动脉内球囊反搏(IABP)来维持其血流动力学。他的病情逐渐好转,并于第28天转至前一家医院进行康复治疗。成人感染性休克使用ECMO并不常见;然而,即使在仔细监测下,严重脓毒症患者也可采用ECMO。新型抗DIC药物rTM有助于在DIC患者中安全使用ECMO。